Voltas. Result Update. Buy. Q4FY18 Result (` Mn) May 21, 2018

Transcription

1 Result Update Voltas Buy Softness seen in AC industry in Q4 has also got spilt over into Q1FY19, with unseasonal showers and lower temperatures playing spoilsport. The next seasonally important quarter is Q4FY19, almost three quarters away. While FY19 is likely to be weak, we continue to like the structural penetration story of ACs and believe Voltas is the best way to play this. We maintain our Buy rating with a target price of ` 65. Q4 was below expectations; Q1 outlook not sanguine too Revenues remained flat at `,484mn in Q4 and grew by 6% YoY at ` 64bn in FY18.EBITDA went up by 15% YoY at ` 2,532mn in Q4, and grew by 17% YoY at ` 6,626mn for the full year. EBITDA margins increased by 161bps YoY at 12.4% for the quarter and up by 1bps YoY at.3% for FY18.Net profits remained flat for the quarter at ` 1,942mn and grew by 11% YoY at `.5779mn in FY18. Unitary cooling segment revenue grew by 7% YoY (after adjusting excise) at `,645 in the quarter, and up by 6% YoY at ` 32bn for FY18. Order inflow in ` 6bn for domestic as well as for international. Current total order book stood at ` 5bn in FY18 v/s ` 43bn in FY17. Similarly, Q1 outlook for the industry is not very positive because of the unseasonal showers witnessed in major parts of the country in May. Inverter ACs-driving the market In total AC market company s share was 19.7% in which has now increased to 22.1% in. Voltas grew higher than the industry for ACs. Inverter ACs contributed % in total sales for FY18, and 3% in. Unitary segment EBIT margins have improved to 17% and company is confident in sustaining the margins at 12-13% level. Voltas s is increasing focus inverter and split ACs. In near future Voltas is thinking of price hike for ACs due to the higher import cost of compressors from China. Voltas is the best way to play the AC structural story We expect Voltas to maintain its leadership in RAC segment and we also don t expect it to lag in inverter ACs. It s JV with Arcelik to launch durables in FY19 will provide a further fillip to growth in the consumer business. It also offers a dual play where apart from the consumer business, the projects business will benefit from the capex cycle. We maintain our Buy rating on the stock with a TP of ` 65(from `693) as we roll back multiples to 3x from 33x earlier. Result (` Mn) Particulars Q4FY17 YoY (%) QoQ (%) Operating Income,484,583 (.5) 13, Cost of material 5,356,318 (48.1) 7,88 (31.4) consumed Purchase of stock,569 3, , Staff cost 1,434 1,485 (3.4) 1,53 (4.6) Other Expenses 1,57 2,35 (26.) 1, EBITDA 2,532 2, , Other Income Depreciation Interest (24.8) Tax Net Profit 1,942 1,998 (2.8) 1, bps bps Raw Material Cost Staff Cost (21).9 (393) Other Expenses (253).4 (33) EBITDA (%) PBT (%) NPM (%) (23) May 21, 18 CMP ` 538 Target / Upside ` 65/21% BSE Sensex 34,683 NSE Nifty,526 Scrip Details Equity / FV Market Cap ` 331mn/`1/- `178bn USD 3bn 52-week High/Low ` 675/44 Avg. Volume (no) 2,132,412 NSE Symbol Bloomberg Code Shareholding Pattern Mar 18 (%) VOLTAS VOLT.IN Promoters 3.3 MF/Banks/FIs 19.2 FIIs 19.8 Public / Others 3.8 Valuation (x) FY18 FY19E FYE P/E EV/EBITDA ROE ROCE Estimates (` mn) FY18 FY19E FYE Net Sales 64,44 7,278 78,832 EBITDA 6,626 7,379 8,277 PAT 5,779 6,434 7,224 EPS (`) Sr. Analyst: Vinod Chari Tel: vinodc@dolatcapital.com Associate: Monali Jain, CA Tel: monalij@dolatcapital.com

2 Sales and QoQ growth EBITDA and QoQ growth (%) Sales(`in Bn) LHS QoQ (%) RHS () (4) (6) 3, 2,5 2, 1,5 1, 5 EBITDA (` In Mn) LHS QoQ (%) RHS 25() 15 5 (5) () Trend in Margin (%) EBITDA margin Net Profit margin Net profit and QoQ growth 2,5 12 2, 8 1,5 6 1, Net Profit(`. In Mn) LHS QoQ (%) RHS () Segmental EBIT margin Trend (%) Electro Mechanical projects and services Engineering products and services Untlity cooling business Order book (` mn) 35, 3, 25,, 15,, 5, FY12 FY13 FY14 FY15 FY16 FY17 F18 Domestic order book International order book May 21, 18 2

3 Income Statement (` mn) Particulars Mar17 Mar18 Mar19E MarE Net Sales 6,328 64,44 7,278 78,832 Total Expenditure 54,659 57,417 62,899 7,555 Cost of materials consumed 42,359 45,675 48,843 54,788 Employee Benefits Exp 6,184 5,867 6,676 7,489 Other Expenses 6,116 5,875 7,379 8,277 Other Income 2,1 1,741 2,8 2,365 EBIDTA (Excl. OI) 5,669 6,626 7,379 8,277 EBIDTA (Incl. OI) 7,789 8,368 9,488,642 Interest Depreciation Profit Before Tax 7,395 8,11 9,62,175 Tax 2,4 2,27 2,628 2,951 Net Profit 5,199 5,779 6,434 7,224 Balance Sheet (` mn) Particulars Mar17 Mar18 Mar19E MarE Sources of Funds Equity Capital Other Reserves 32,735 38,721 38,475 44,748 Net Worth 33,66 39,52 38,85 45,79 Secured Loans Loan Funds 1,79 1,423 1,757 1,971 Deferred Tax Liability (198) (46) (46) (46) Total Capital Employed 34,863 4,746 4,834 47,321 Applications of Funds Gross Block 4,63 5,73 5,543 6,13 Less: Accu. Depreciation 2,784 3,28 3,277 3,548 Net Block 2,999 2,972 2,989 3,189 Capital Work in Progress Investments 22,679 27,536 26,155 26,655 Current Assets, Loans & Advances Inventories 9,7 8,13 8,857 9,935 Sundry Debtors 14,541 15,73 16,366 18,358 Cash and Bank Balance 3,314 2,837,822 16,96 Loans and Advances sub total 38,88 42,37 47,784 57,557 Less: Current Liabilities & Provisions Current Liabilities 26,945 29,443 33,457 37,126 Provisions 2,685 2,442 2,678 2,995 sub total 29,63 31,885 36,135 4,121 Net Current Assets 9,178,485 11,649 17,436 Total Assets 34,863 4,746 4,834 47,321 E Estimates Cash Flow (` mn) Particulars Mar17 Mar18 Mar19E MarE Profit before tax 5,425 6,383 7,13 8,7 Depreciation & w.o Net Interest Exp 2,1 1,741 2,8 2,365 Direct taxes paid (2,4) (2,27) (2,628) (2,951) Change in Working Capital 535 (1,784) 6,821 (513) (A) CF from Opt. Activities 7,735 6,7 8,4 7,43 Capex (1,284) (251) (267) (47) Free Cash Flow 6,451 5,819 7,773 6,573 (B) CF from Invt. Activities (4,55) (5,9) 1,114 (97) Inc./(Dec.) in Debt (998) (287) Interest exp. net (16) (119) (176) (197) Dividend Paid (Incl. Tax) (9) (1,323) (951) (951) (C) CF from Financing (2,59) (1,729) (793) (934) Net Change in Cash 1,169 (48) 7,985 5,274 Opening Cash balances 2,145 3,317 2,837,822 Closing Cash balances 3,314 2,837,822 16,96 Important Ratios Particulars Mar17 Mar18 Mar19E MarE (A) Measures of Performance (%) EBIDTA Margin (excl. O.I.) Interest / Sales Tax/PBT Net Profit Margin (B) As Percentage of Net Sales Raw Material Employee Expenses Other Expenses (C) Measures of Financial Status Debt / Equity (x).1... Interest Coverage (x) Average Cost of Debt (%) Debtors Period (days) Closing stock (days) Inventory Turnover Ratio (x) Fixed Assets Turnover (x) W.C. Turnover (x) Non-Cash WC (` Mn) 5,864 7, ,34 (D) Measures of Investment EPS (`) (excl EO) CEPS (`) DPS (`) Dividend Payout (%) Profit Ploughback (%) Book Value (`) RoANW (%) RoACE (%) RoAIC (%) (E) Valuation Ratios CMP (`) P/E (x) Market Cap. (` Mn.) 177, , , ,945 MCap/ Sales (x) EV (` Mn.) 176,34 176, ,88 163,819 EV/Sales (x) EV/EBDITA (x) P/BV (x) Dividend Yield (%) E Estimates May 21, 18 3

4 DART RATING MATRIX Total Return Expectation (12 Months) Buy > % Accumulate to % Reduce to % Sell < % Rating and Target Price History 75 Month Rating TP (`) Price (`)* 7 65 Mar 18 Buy * As on Recommendation Date 4 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Voltas Target DART Team Purvag Shah Managing Director purvag@dolatcapital.com Amit Khurana, CFA Head of Equities amit@dolatcapital.com CONTACT DETAILS Equity Sales Designation Direct Lines Dinesh Bajaj VP - Equity Sales dineshb@dolatcapital.com Kartik Sadagopan VP - Equity Sales kartiks@dolatcapital.com Kapil Yadav VP - Equity Sales kapil@dolatcapital.com Derivatives Strategist Designation Bhavin Mehta VP - Derivatives Strategist bhavinm@dolatcapital.com Equity Trading Designation P. Sridhar VP and Head of Sales Trading sridhar@dolatcapital.com Chandrakant Ware AVP - Equity Sales Trading chandrakant@dolatcapital.com Derivatives Trading Designation Shirish Thakkar AVP - Derivatives shirisht@dolatcapital.com Hardik Mehta Sales Trader hardikm@dolatcapital.com Dolat Capital Market Private Limited., Rajabahadur Mansion, 1st Floor, Ambalal Doshi Marg, Fort, Mumbai - 4 1

5 Analyst(s) Certification The research analyst(s), with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in this research report. I. Analyst(s) and Associate (S) holding in the Stock(s): (Nil) II. Disclaimer: This research report has been prepared by Dolat Capital Market Private Limited. to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies) solely for the purpose of information of the select recipient of this report. This report and/or any part thereof, may not be duplicated in any form and/or reproduced or redistributed without the prior written consent of Dolat Capital Market Private Limited. This report has been prepared independent of the companies covered herein. Dolat Capital Market Private Limited. and its affiliated companies are part of a multi-service, integrated investment banking, brokerage and financing group. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have provided or may provide services in respect of managing offerings of securities, corporate finance, investment banking, mergers & acquisitions, financing or any other advisory services to the company(ies) covered herein. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have received or may receive compensation from the company(ies) mentioned in this report for rendering any of the above services. Research analysts and sales persons of Dolat Capital Market Private Limited. may provide important inputs to its affiliated company(ies) associated with it. While reasonable care has been taken in the preparation of this report, it does not purport to be a complete description of the securities, markets or developments referred to herein, and Dolat Capital Market Private Limited. does not warrant its accuracy or completeness. Dolat Capital Market Private Limited. may not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. This report is provided for information only and is not an investment advice and must not alone be taken as the basis for an investment decision. The investment discussed or views expressed herein may not be suitable for all investors. The user assumes the entire risk of any use made of this information. The information contained herein may be changed without notice and Dolat Capital Market Private Limited. reserves the right to make modifications and alterations to this statement as they may deem fit from time to time. Dolat Capital Market Private Limited. and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. This report is neither an offer nor solicitation of an offer to buy and/or sell any securities mentioned herein and/or not an official confirmation of any transaction. This report is not directed or intended for distribution to, or use by any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject Dolat Capital Market Private Limited. and/or its affiliated company(ies) to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to a certain category of investors. Persons in whose possession this report may come, are required to inform themselves of and to observe such restrictions. For U.S. Entity/ persons only: This research report is a product of Dolat Capital Market Private Limited., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Dolat Capital Market Private Limited. only to "Major Institutional Investors" as defined by Rule 15a- 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person or entity. In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Dolat Capital Market Private Limited. has entered into an agreement with a U.S. registered broker-dealer Ltd Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer/entity as informed by Dolat Capital Market Private Limited. from time to time. Dolat Capital Market Private Limited. Corporate Identity Number: U6599DD1993PTC9797 Member: BSE Limited and National Stock Exchange of India Limited. SEBI Registration No: BSE - INB752 & INF752, NSE - INB23731& INF23731, Research: INH685 Registered office: Office No. 141, Centre Point, Somnath, Daman 396 2, Daman & Diu Board: Fax: research@dolatcapital.com Our Research reports are also available on Reuters, Thomson Publishers, DowJones and Bloomberg (DCML <GO>)